Merck KGaA (OTCMKTS:MKGAF) Hits New 12-Month Low – Time to Sell?

Merck KGaA (OTCMKTS:MKGAF)’s share price hit a new 52-week low during trading on Thursday . The stock traded as low as $142.05 and last traded at $142.05, with a volume of 228 shares. The stock had previously closed at $145.80.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group upgraded Merck KGaA to a “strong-buy” rating in a report on Thursday, September 19th.

Merck KGaA Price Performance

The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The company has a fifty day moving average price of $156.52 and a two-hundred day moving average price of $170.68. The firm has a market cap of $18.52 billion, a P/E ratio of 21.88 and a beta of 0.96.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.